What is the role of empiric therapy in the treatment of breast abscesses and masses?

Updated: Jul 27, 2020
  • Author: Andrew C Miller, MD; Chief Editor: Jeter (Jay) Pritchard Taylor, III, MD  more...
  • Print

Empiric therapy should have activity against S aureus, a common pathogen of primary breast abscess. Other pathogens may include methicillin-resistant S aureus (MRSA), Streptococcus pyogenes, E coli, Bacteroides species, Corynebacterium species, coagulase-negative staphylococci, Pseudomonasaeruginosa, Proteusmirabilis, and anaerobes. Therapy should be tailored to results of cultures and susceptibilities, if applicable.

Recurrent breast abscesses have an increased risk for mixed flora and anaerobic pathogens.

Antibiotics should be continued for 10-14 days.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!